Skip to main content
who's buying and selling

SunOpta operates a healthy food products business through two segments: global ingredients and consumer products. The stock had a rough first half of 2016, hitting a low of $4.14 on May 24. Fortunes turned up a few days later when management indicated a willingness to talk to institutional investors about changes. On Oct. 7, SunOpta announced a strategic arrangement with Oaktree Capital Management, including the appointment of Dean Hollis to the board. He is now chairman and on Nov. 11 bought 50,000 shares at an average price of $8.83.

Ted Dixon is CEO of INK Research which provides insider news and knowledge to investors. For more background on insider reporting in Canada, visit the FAQ section at www.inkresearch.com. Securities referenced in this profile may have already appeared in recent reports distributed to INK subscribers. INK staff may also hold a position in profiled securities.

Graph Footnote:

Chart reflects public-market transactions of common shares or unit trusts by company officers and directors.